Transfer tehnologije u procesu nastanka cjepiva

master's thesis

• Title (english): Technology transfer in the vaccine development process
• Author: Vlado Maslać
• Mentor: Ivana Kovač (mentor); MBZ: 323644
• Committee member: Ivana Kovač (predsjednik povjerenstva)
• Committee member: Mihaela Mikić (član povjerenstva)
• Committee member: Mladen Turuk (član povjerenstva)
• Granter: University of Zagreb; Faculty of Economics and Business; (Department of International Economics); Zagreb
• Defense date and country: 2021-12-16, Croatia
• Scientific / art field, discipline and subdiscipline: SOCIAL SCIENCES; Economics; International Economics

Abstract

Transfer tehnologije ubrzava uspješno usvajanje inovacija. Pritom se nastoji znanje i tehnologiju razvijenu u svojim javnim laboratorijima učiniti dostupnim javnim i privatnim subjektima na različite načine, Transfer tehnologije ključni je čimbenik koji snažno utječe na gospodarski rast, kratkoročno i dugoročno. Strukturne promjene cjelokupnog gospodarstva gotovo su nemoguće bez učinkovitog transfera tehnologije i dobro definiranog inovacijskog sustava zemlje. Prijenos tehnologije cjepiva može imati ogroman utjecaj na pristup cjepivima i kasnija poboljšanja zdravlja. Iako su se cjepiva protiv COVID-19 brzo razvijala, poduzeti su svi koraci kako bi se osigurala njihova sigurnost i učinkovitost. Može se zaključiti kako su cjepiva protiv COVID-19 brzo razvijena i distribuirana kako bi pomogla u borbi protiv pandemije. U Europskoj uniji, pa tako i u Republici Hrvatskoj, trenutačno su odobrena sljedeća cjepiva protiv bolesti COVID-19- cjepivo Comirnatym (Australija), cjepivo Spikevax (Španjolska), cjepivo Vaxzevria (Velika Britanija) te cjepivo COVID-19 Vaccine Janssen (Belgija). Može se zaključiti kako je u svim zemljama proizvođačima cjepiva za COVID-19 došlo do povećanja bruto domaćeg proizvoda što se može povezati sa interesom zemalja za nabavkom odgovarajućeg cjepiva kako bi se pandemija konačno privela svom kraju.

Abstract (english)

Technology transfer accelerates the successful adoption of innovations. In doing so, it seeks to make the knowledge and technology developed in its public laboratories available to public and private entities in a variety of ways. Technology transfer is a key factor that strongly influences economic growth, both short-term and long-term. Structural changes to the entire economy are almost impossible without effective technology transfer and a well-defined innovation system of the country. The transfer of vaccine technology can have a huge impact on vaccine access and subsequent health improvements. Although vaccines against COVID-19 have developed rapidly, all steps have been taken to ensure their safety and efficacy. It can be concluded that vaccines against COVID-19 were rapidly developed and distributed to help combat the pandemic. The following COVID-19 vaccines are currently approved in the European Union, including the Republic of Croatia - Comirnatym (Australia), Spikevax (Spain), Vaxzevria (UK) and COVID-19 Vaccine Janssen (Belgium). It can be concluded that in all countries producing vaccines for COVID-19 there has been an increase in gross domestic product which can be linked to the interest of countries in procuring the appropriate vaccine to finally bring the pandemic to an end.

• Keywords: transfer tehnologije; cjepiva; COVID-19; kraj pandemije
• Keywords (english): technology transfer; vaccines; COVID-19; end of the pandemic
• Language: croatian
• URN:NBN: urn:nbn:hr:148:207930
• Study programme: Title: Economics of Entrepreneurship; Study programme type: professional; Study level: specialist graduate; Academic / professional title: stručni specijalist/specijalistica poduzetništva (stručni specijalist/specijalistica poduzetništva)
• Type of resource: Text
• File origin: Born digital
• Access conditions: Access restricted to students and staff of home institution
• Created on: 2021-12-27 10:04:46